Skip to main content
Caplight Logo









biotx.ai GmbH

biotx.ai GmbH

Private
PotsdamHealthcare & Life Scienceshttps://www.biotx.ai/

Last Round

Early Funding

Feb 1, 2023

Total Funding Raised

$2.85M

Company Overview

biotx.ai GmbH is a biotechnology company that provides an AI-driven drug discovery platform using causal modeling and Mendelian randomization to identify therapeutic targets and predict clinical trial outcomes for the biopharma industry.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Clinical Trials, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

causal AIdrug discoverysynthetic clinical trialsgenomic data analysistarget discoveryMendelian randomizationTechBioAI drug discoveryclinical trial predictiongenome-wide association studyGWASprecision medicinein silico trialsdrug development pipelinebiobank data

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

biotx.ai GmbH Comparables

Compare biotx.ai GmbH with similar companies based on industry and business-model similarity.

biotx.ai GmbH comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Engine Biosciences
86%
5 Prime Sciences
86%
Aitia
81%

biotx.ai GmbH Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingFeb 1, 2023
GrantMay 31, 2018

Key People

Founding team and executive leadership

Joern Klinger

CEO, Co-CEO & CTO

Executive Team

Charles Ravarani

Chief Technology Officer

Executive Team

biotx.ai GmbH Investors

Notable investors and investment history

biotx.ai GmbH investors
InvestorRounds
Think.HealthEarly Funding
Peak PrideEarly Funding
European Regional Development Fund (ERDF)Grant
Brandenburg KapitalEarly Funding
SquareOne Venture CapitalEarly Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 21, 2026

    Monthly visitors increased 73% MoM, reaching 1.2K.

  • Mar 1, 2026

    Monthly visitors increased 186% MoM.

biotx.ai GmbH Filings

Explore SEC and related filing metadata, where available.

biotx.ai GmbH filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about biotx.ai GmbH's valuation, stock price, and market status.

Is biotx.ai GmbH a public or private company?

biotx.ai GmbH is a private company.

What is the current stock price of biotx.ai GmbH?

biotx.ai GmbH is a private company with no public stock price. No recent secondary market data is available.

How much is biotx.ai GmbH worth (valuation)?

Valuation information for biotx.ai GmbH is not publicly available.

Can I buy biotx.ai GmbH stock?

biotx.ai GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was biotx.ai GmbH's last funding round?

biotx.ai GmbH's most recent funding round was Early Funding on February 1, 2023.

Who are the main investors in biotx.ai GmbH?

Key investors in biotx.ai GmbH include Think.Health, Peak Pride, Brandenburg Kapital, SquareOne Venture Capital.

Will biotx.ai GmbH IPO soon?

No public IPO plans have been announced for biotx.ai GmbH.

How can I track biotx.ai GmbH secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor biotx.ai GmbH's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersPotsdam
Employee Range15
Year Founded2017
Last FundingFeb 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?